ENZO BIOCHEM INC  ENZO 2ND QTR JAN 31 NET NEW YORK MARCH 13 SHR ONE CT VS THREE CTS NET 123000 VS 371000 REVS 2944000 VS 2138000 AVG SHRS 114 MLN VS 116 MLN SIX MTHS SHR FIVE CTS VS SIX CTS NET 531000 VS 725000 REVS 6200000 VS 4128000 AVG SHRS 114 MLN VS 116 MLN   